Pharma Biomarker Co-Development: Advancing Precision Medicine
Pharma biomarker co-development accelerates targeted therapies by synchronizing safety, efficacy, and regulatory milestones with companion diagnostics.
This collaborative approach enhances trial design, reduces risk, and supports faster, more informed decisions in precision medicine development.